AlphaYouHB
Insider selling
Harold Bernstein sold $255K of Maze Therapeutics, Inc. (MAZE) stock
Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 9,705 shares of MAZE stock worth $255K, per an SEC Form 4 filed Sep 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 4, 2026, 4 days before it was made public.
MAZE has moved +8.3% since the trade date, from $26.21 to $28.38 (Sep 22, 2026 close).
- Traded
- Sep 4, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 4 days
- Price since
- +8.3%
- Role
- President, R&D & CMO
- Source
- SEC Form 4
More MAZE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.